122 related articles for article (PubMed ID: 22892121)
1. Novel monobactams utilizing a siderophore uptake mechanism for the treatment of gram-negative infections.
Mitton-Fry MJ; Arcari JT; Brown MF; Casavant JM; Finegan SM; Flanagan ME; Gao H; George DM; Gerstenberger BS; Han S; Hardink JR; Harris TM; Hoang T; Huband MD; Irvine R; Lall MS; Megan Lemmon M; Li C; Lin J; McCurdy SP; Mueller JP; Mullins L; Niosi M; Noe MC; Pattavina D; Penzien J; Plummer MS; Risley H; Schuff BP; Shanmugasundaram V; Starr JT; Sun J; Winton J; Young JA
Bioorg Med Chem Lett; 2012 Sep; 22(18):5989-94. PubMed ID: 22892121
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and biological evaluation of monobactams as antibacterial agents against gram-negative bacteria.
Fu HG; Hu XX; Li CR; Li YH; Wang YX; Jiang JD; Bi CW; Tang S; You XF; Song DQ
Eur J Med Chem; 2016 Mar; 110():151-63. PubMed ID: 26827160
[TBL] [Abstract][Full Text] [Related]
3. Discovery of Novel Pyridone-Conjugated Monosulfactams as Potent and Broad-Spectrum Antibiotics for Multidrug-Resistant Gram-Negative Infections.
Tan L; Tao Y; Wang T; Zou F; Zhang S; Kou Q; Niu A; Chen Q; Chu W; Chen X; Wang H; Yang Y
J Med Chem; 2017 Apr; 60(7):2669-2684. PubMed ID: 28287720
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and biological evaluation of C(4) substituted monobactams as antibacterial agents against multidrug-resistant Gram-negative bacteria.
Kou Q; Wang T; Zou F; Zhang S; Chen Q; Yang Y
Eur J Med Chem; 2018 May; 151():98-109. PubMed ID: 29605810
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antibacterial evaluation of new monobactams.
Thu ZM; Sun J; Ji J; He L; Ji J; Iqbal Z; Myo KK; Gao Y; Zhai L; Mu Y; Tang D; Vidari G; Yang H; Yang Z
Bioorg Med Chem Lett; 2021 May; 39():127878. PubMed ID: 33636305
[TBL] [Abstract][Full Text] [Related]
6. Pyridone-conjugated monobactam antibiotics with gram-negative activity.
Brown MF; Mitton-Fry MJ; Arcari JT; Barham R; Casavant J; Gerstenberger BS; Han S; Hardink JR; Harris TM; Hoang T; Huband MD; Lall MS; Lemmon MM; Li C; Lin J; McCurdy SP; McElroy E; McPherson C; Marr ES; Mueller JP; Mullins L; Nikitenko AA; Noe MC; Penzien J; Plummer MS; Schuff BP; Shanmugasundaram V; Starr JT; Sun J; Tomaras A; Young JA; Zaniewski RP
J Med Chem; 2013 Jul; 56(13):5541-52. PubMed ID: 23755848
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of the novel monosulfactam BAL30072 alone and in combination with meropenem versus a diverse collection of important Gram-negative pathogens.
Hornsey M; Phee L; Stubbings W; Wareham DW
Int J Antimicrob Agents; 2013 Oct; 42(4):343-6. PubMed ID: 23837926
[TBL] [Abstract][Full Text] [Related]
8. Will new antimicrobials overcome resistance among Gram-negatives?
Bassetti M; Ginocchio F; Mikulska M; Taramasso L; Giacobbe DR
Expert Rev Anti Infect Ther; 2011 Oct; 9(10):909-22. PubMed ID: 21973303
[TBL] [Abstract][Full Text] [Related]
9. Preparation and antibiotic activity of monobactam analogues of nocardicins.
Gerardin-Charbonnier C; Auberger S; Molina L; Achilefu S; Manresa MA; Vinardell P; Infante MR; Selve C
Prep Biochem Biotechnol; 1999 Aug; 29(3):257-72. PubMed ID: 10431930
[TBL] [Abstract][Full Text] [Related]
10. The antibiotic pipeline for multi-drug resistant gram negative bacteria: what can we expect?
Falagas ME; Mavroudis AD; Vardakas KZ
Expert Rev Anti Infect Ther; 2016 Aug; 14(8):747-63. PubMed ID: 27400643
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of 'old antibiotics' against highly resistant Gram-negative bacteria.
Dubourg G; Okdah L; Le Page S; Rolain JM; Raoult D
Int J Antimicrob Agents; 2015 Dec; 46(6):718-20. PubMed ID: 26589488
[No Abstract] [Full Text] [Related]
12. Synthesis and antimicrobial properties of substituted 3-aminoxypropionyl and 3-aminoxy-(E)-2-methoxyiminopropionyl monobactams.
Balsamo A; Macchia B; Orlandini E; Rossello A; Macchia F; Broccali G; Fonio W
Farmaco; 1990 Jul; 45(7-8):879-88. PubMed ID: 2282121
[TBL] [Abstract][Full Text] [Related]
13. Azetidinone-isothiazolidinones: stereoselective synthesis and antibacterial evaluation of new monocyclic beta-lactams.
Cerić H; Sindler-Kulyk M; Kovacević M; Perić M; Zivković A
Bioorg Med Chem; 2010 May; 18(9):3053-8. PubMed ID: 20382539
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antibacterial activity of C-4 thio- and dithiocarbamate monobactam derivatives.
Cascio G; Lorenzi L; Caglio D; Manghisi E; Arcamone F; Guanti G; Satta G; Morandotti G; Sperning R
Farmaco; 1996 Mar; 51(3):189-96. PubMed ID: 8688141
[TBL] [Abstract][Full Text] [Related]
15. Pyridone methylsulfone hydroxamate LpxC inhibitors for the treatment of serious gram-negative infections.
Montgomery JI; Brown MF; Reilly U; Price LM; Abramite JA; Arcari J; Barham R; Che Y; Chen JM; Chung SW; Collantes EM; Desbonnet C; Doroski M; Doty J; Engtrakul JJ; Harris TM; Huband M; Knafels JD; Leach KL; Liu S; Marfat A; McAllister L; McElroy E; Menard CA; Mitton-Fry M; Mullins L; Noe MC; O'Donnell J; Oliver R; Penzien J; Plummer M; Shanmugasundaram V; Thoma C; Tomaras AP; Uccello DP; Vaz A; Wishka DG
J Med Chem; 2012 Feb; 55(4):1662-70. PubMed ID: 22257165
[TBL] [Abstract][Full Text] [Related]
16. Emerging resistance in Gram-negative pathogens and implications for clinical practice.
Cantón R; Lumb J
Future Microbiol; 2011 Jan; 6(1):19-22. PubMed ID: 21162632
[TBL] [Abstract][Full Text] [Related]
17. [BAL30072--an iron complexing beta lactam antibiotic against multidrug-resistant gram negative bacteria].
Schmitz J
Pharm Unserer Zeit; 2011 Mar; 40(2):98-9. PubMed ID: 21630531
[No Abstract] [Full Text] [Related]
18. Activity of BAL30376 (monobactam BAL19764 + BAL29880 + clavulanate) versus Gram-negative bacteria with characterized resistance mechanisms.
Livermore DM; Mushtaq S; Warner M
J Antimicrob Chemother; 2010 Nov; 65(11):2382-95. PubMed ID: 20846937
[TBL] [Abstract][Full Text] [Related]
19. Development of new polymyxin derivatives for multi-drug resistant Gram-negative infections.
Brown P; Dawson MJ
J Antibiot (Tokyo); 2017 Apr; 70(4):386-394. PubMed ID: 28074057
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial resistance among and therapeutic options against gram-negative pathogens.
Rahal JJ
Clin Infect Dis; 2009 Aug; 49 Suppl 1():S4-S10. PubMed ID: 19619021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
